Show simple item record

dc.contributor.authorValero, C.
dc.contributor.authorPérez Castrillón, José Luis
dc.contributor.authorZarrabeitia, M. T.
dc.contributor.authorHernández, J. L.
dc.contributor.authorAlonso, María A.
dc.contributor.authorPino-Montes, J. del
dc.contributor.authorOlmos, José M.
dc.contributor.authorGonzález-Macías, Jesús
dc.contributor.authorRiancho, José A.
dc.date.accessioned2014-09-04T10:22:40Z
dc.date.available2014-09-04T10:22:40Z
dc.date.issued2008
dc.identifier.citationOsteoporosis International, 2008, vol. 19, p. 787-792es
dc.identifier.issn0937-941Xes
dc.identifier.urihttp://uvadoc.uva.es/handle/10324/5832
dc.descriptionProducción Científicaes
dc.description.abstractSummary Two polymorphisms of the aromatase and estrogen receptor genes appeared to interact to influence the risk of hip fractures in women. Introduction Allelic variants of the aromatase gene have been associated with bone mineral density and vertebral fractures. Our objective was to analyze the relationship between two polymorphisms of the aromatase and estrogen receptor genes and hip fractureses
dc.format.mimetypeapplication/pdfes
dc.language.isoenges
dc.publisherInternational Osteoporosis Foundation and National Osteoporosis Foundationes
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectOsteoporosis-Tratamientoes
dc.subjectCadera-Fracturases
dc.titleAssociation of aromatase and estrogen receptor gene polymorphisms with hip fractureses
dc.typeinfo:eu-repo/semantics/articlees
dc.identifier.doi10.1007/s00198-007-0491-0es
dc.identifier.publicationfirstpage787es
dc.identifier.publicationlastpage792es
dc.identifier.publicationtitleOsteoporosis Internationales
dc.identifier.publicationvolume19es
dc.peerreviewedSIes
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record